Novel Keap1-Nrf2 Inhibitors as Chemopreventive Agents

作为化学预防剂的新型 Keap1-Nrf2 抑制剂

基本信息

  • 批准号:
    7321003
  • 负责人:
  • 金额:
    $ 7.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Research over the last decade has demonstrated that Keap1-Nrf2-antioxidant response element (ARE) system plays a key role in cancer chemoprevention by many chemicals like sulforaphane, curcumin, and epigallo- catechol gallate derived from natural sources such as fruits, vegetables, and tea products. Modification, by these natural electrophiles such as isothiocyanates and Michael acceptors, of sensitive cysteine residues found in the redox "sensor" protein Keap1 is believed to be responsible for causing the dissociation of Keap1- Nrf2 complex and subsequent upregulation of oxidative stress response enzymes. To address concerns over the general use of purified natural thiol-reactive compounds as chemopreventive agents, novel short peptides and small organic molecules are designed and screened specifically for the inhibition of Keap1-Nrf2 interaction. These inhibitors will mimic the actions of reactive oxygen species and electrophiles like isothiocyanates and Michael acceptors in the induction of cytoprotective enzymes but will potentially be more selective and specific. Two structure-based approaches are proposed here to start from the recently available 3-D X-ray cocrystal structure of Keap1 Kelch domain with Nrf2 peptide to discover novel selective Keap1-Nrf2 inhibitors: a) to design conformationally restricted cyclic peptides to mimic the ¿-hairpin loop of Nrf2 that interacts with Keap1 and b) to use in silico screening of virtual libraries for small molecules that could bind to Keap1 with high affinity and thus prevent the binding of Nrf2. These studies will provide important information about, and novel small molecule inhibitors of, the protein-protein interaction between Keap1 and Nrf2, and facilitate the development of more potent and selective Keap1-Nrf2 inhibitors as inducers of oxidative stress response enzymes.
描述(由申请人提供): 过去十年的研究表明,Keap 1-Nrf 2-抗氧化反应元件(ARE)系统在许多化学物质(如萝卜硫素、姜黄素和表没食子儿茶酚没食子酸酯)的癌症化学预防中发挥着关键作用,这些化学物质来源于水果、蔬菜和茶产品等天然来源。通过这些天然亲电体如异硫氰酸酯和迈克尔受体,在氧化还原“传感器”蛋白Keap 1中发现的敏感半胱氨酸残基的修饰被认为是导致Keap 1-Nrf 2复合物解离和随后氧化应激反应酶上调的原因。为了解决纯化的天然硫醇反应性化合物作为化学预防剂的一般用途的问题,新的短肽和小的有机分子被设计和筛选,特别是用于抑制Keap 1-Nrf 2相互作用。这些抑制剂将模拟活性氧和亲电体如异硫氰酸酯和迈克尔受体在诱导细胞保护酶中的作用,但可能更具选择性和特异性。本文提出了两种基于结构的方法,从最近获得的Keap 1 Kelch结构域与Nrf 2肽的三维X射线共晶结构出发,发现新的选择性Keap 1-Nrf 2抑制剂:a)设计构象限制性环肽,模拟Nrf 2肽的构象,- 与Keap 1相互作用的Nrf 2的发夹环,和B)使用计算机模拟筛选虚拟文库中的小分子,这些小分子可以以高亲和力与Keap 1结合,从而阻止Nrf 2的结合。这些研究将提供有关Keap 1和Nrf 2之间蛋白质-蛋白质相互作用的重要信息和新型小分子抑制剂,并促进开发更有效和选择性的Keap 1-Nrf 2抑制剂作为氧化应激反应酶的诱导剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LONGQIN HU其他文献

LONGQIN HU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LONGQIN HU', 18)}}的其他基金

L-Cystine Diamides as Inhibitors of L-Cystine Stone Formation in Cystinuria
L-胱氨酸二酰胺作为胱氨酸尿症中 L-胱氨酸结石形成的抑制剂
  • 批准号:
    10083210
  • 财政年份:
    2017
  • 资助金额:
    $ 7.73万
  • 项目类别:
HTS fluorescence polarization assay for inhibitors of Keap1-Nrf2 interaction
Keap1-Nrf2 相互作用抑制剂的 HTS 荧光偏振测定
  • 批准号:
    8070110
  • 财政年份:
    2010
  • 资助金额:
    $ 7.73万
  • 项目类别:
HTS fluorescence polarization assay for inhibitors of Keap1-Nrf2 interaction
Keap1-Nrf2 相互作用抑制剂的 HTS 荧光偏振测定
  • 批准号:
    8204553
  • 财政年份:
    2010
  • 资助金额:
    $ 7.73万
  • 项目类别:
Optimization of EphA subtype-selective antagonists as probes for the nervous syst
EphA亚型选择性拮抗剂作为神经系统探针的优化
  • 批准号:
    7936819
  • 财政年份:
    2009
  • 资助金额:
    $ 7.73万
  • 项目类别:
Homogenous HTS Assays to Screen for Inhibitors of Keap1-Nrf2 Interaction
用于筛选 Keap1-Nrf2 相互作用抑制剂的同质 HTS 测定
  • 批准号:
    7902191
  • 财政年份:
    2008
  • 资助金额:
    $ 7.73万
  • 项目类别:
Homogenous HTS Assays to Screen for Inhibitors of Keap1-Nrf2 Interaction
用于筛选 Keap1-Nrf2 相互作用抑制剂的同质 HTS 测定
  • 批准号:
    7691725
  • 财政年份:
    2008
  • 资助金额:
    $ 7.73万
  • 项目类别:
Novel Keap1-Nrf2 Inhibitors as Chemopreventive Agents
作为化学预防剂的新型 Keap1-Nrf2 抑制剂
  • 批准号:
    7455941
  • 财政年份:
    2007
  • 资助金额:
    $ 7.73万
  • 项目类别:
Structure-Based Design of Eph Receptor Antagonists
Eph 受体拮抗剂的基于结构的设计
  • 批准号:
    6861086
  • 财政年份:
    2004
  • 资助金额:
    $ 7.73万
  • 项目类别:
Structure-Based Design of Eph Receptor Antagonists
Eph 受体拮抗剂的基于结构的设计
  • 批准号:
    6718126
  • 财政年份:
    2004
  • 资助金额:
    $ 7.73万
  • 项目类别:
MECHANISM BASED INHIBITION OF CYCLIN DEPENDENT KINASES
基于机制的细胞周期依赖性激酶抑制
  • 批准号:
    6090936
  • 财政年份:
    2000
  • 资助金额:
    $ 7.73万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了